APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pirfenidone Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pirfenidone Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174026040327 December 2025180 pages

Choose your research edition.

Industry ResearchPirfenidone Tablets Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pirfenidone Tablets Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Pirfenidone Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pirfenidone Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pirfenidone Tablets Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Pirfenidone Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pirfenidone Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pirfenidone Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pirfenidone Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pirfenidone Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pirfenidone Tablets include Teva, Roche, Kawin, ScieGen Pharmaceuticals, Sandoz, Apotex, Amneal Pharmaceuticals and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pirfenidone Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pirfenidone Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pirfenidone Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pirfenidone Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Pirfenidone Tablets Segment by Company

Teva

Roche

Kawin

ScieGen Pharmaceuticals

Sandoz

Apotex

Amneal Pharmaceuticals

Accord Healthcare

Pirfenidone Tablets Segment by Type

200mg per Tablet

267mg per Tablet

801mg per Tablet

Pirfenidone Tablets Segment by Application

Retail Pharmacies

Hospital and Clinic

Other

Pirfenidone Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pirfenidone Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pirfenidone Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pirfenidone Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pirfenidone Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pirfenidone Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pirfenidone Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pirfenidone Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pirfenidone Tablets Industry Trends Table 2. Pirfenidone Tablets Industry Drivers Table 3. Pirfenidone Tablets Industry Opportunities and Challenges Table 4. Pirfenidone Tablets Industry Restraints Table 5. Global Pirfenidone Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pirfenidone Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pirfenidone Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pirfenidone Tablets Sales Market Share by Manufacturers Table 9. Global Pirfenidone Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pirfenidone Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pirfenidone Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pirfenidone Tablets Manufacturers, Product Type & Application Table 13. Global Pirfenidone Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pirfenidone Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 200mg per Tablet Table 17. Major Manufacturers of 267mg per Tablet Table 18. Major Manufacturers of 801mg per Tablet Table 19. Global Pirfenidone Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Pirfenidone Tablets Sales by Type (2021-2026) & (K Units) Table 21. Global Pirfenidone Tablets Sales by Type (2027-2032) & (K Units) Table 22. Global Pirfenidone Tablets Sales Market Share by Type (2021-2026) Table 23. Global Pirfenidone Tablets Sales Market Share by Type (2027-2032) Table 24. Global Pirfenidone Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Pirfenidone Tablets Revenue by Type (2021-2026) & (K Units) Table 26. Global Pirfenidone Tablets Revenue by Type (2027-2032) & (K Units) Table 27. Global Pirfenidone Tablets Revenue Market Share by Type (2021-2026) Table 28. Global Pirfenidone Tablets Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Retail Pharmacies Table 30. Major Manufacturers of Hospital and Clinic Table 31. Major Manufacturers of Other Table 32. Global Pirfenidone Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Pirfenidone Tablets Sales by Application (2021-2026) & (K Units) Table 34. Global Pirfenidone Tablets Sales by Application (2027-2032) & (K Units) Table 35. Global Pirfenidone Tablets Sales Market Share by Application (2021-2026) Table 36. Global Pirfenidone Tablets Sales Market Share by Application (2027-2032) Table 37. Global Pirfenidone Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Pirfenidone Tablets Revenue by Application (2021-2026) & (K Units) Table 39. Global Pirfenidone Tablets Revenue by Application (2027-2032) & (K Units) Table 40. Global Pirfenidone Tablets Revenue Market Share by Application (2021-2026) Table 41. Global Pirfenidone Tablets Revenue Market Share by Application (2027-2032) Table 42. Global Pirfenidone Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pirfenidone Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Pirfenidone Tablets Sales Market Share by Region (2021-2026) Table 45. Global Pirfenidone Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Pirfenidone Tablets Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pirfenidone Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Pirfenidone Tablets Sales by Country (2021-2026) & (K Units) Table 49. North America Pirfenidone Tablets Sales by Country (2027-2032) & (K Units) Table 50. Europe Pirfenidone Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Pirfenidone Tablets Sales by Country (2021-2026) & (K Units) Table 52. Europe Pirfenidone Tablets Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Pirfenidone Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Pirfenidone Tablets Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Pirfenidone Tablets Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Pirfenidone Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Pirfenidone Tablets Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Pirfenidone Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Pirfenidone Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pirfenidone Tablets Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pirfenidone Tablets Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pirfenidone Tablets Revenue Market Share by Region (2021-2026) Table 63. Global Pirfenidone Tablets Revenue Market Share by Region (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Pirfenidone Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Pirfenidone Tablets Product Portfolio Table 68. Teva Recent Development Table 69. Roche Company Information Table 70. Roche Business Overview Table 71. Roche Pirfenidone Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Roche Pirfenidone Tablets Product Portfolio Table 73. Roche Recent Development Table 74. Kawin Company Information Table 75. Kawin Business Overview Table 76. Kawin Pirfenidone Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Kawin Pirfenidone Tablets Product Portfolio Table 78. Kawin Recent Development Table 79. ScieGen Pharmaceuticals Company Information Table 80. ScieGen Pharmaceuticals Business Overview Table 81. ScieGen Pharmaceuticals Pirfenidone Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. ScieGen Pharmaceuticals Pirfenidone Tablets Product Portfolio Table 83. ScieGen Pharmaceuticals Recent Development Table 84. Sandoz Company Information Table 85. Sandoz Business Overview Table 86. Sandoz Pirfenidone Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sandoz Pirfenidone Tablets Product Portfolio Table 88. Sandoz Recent Development Table 89. Apotex Company Information Table 90. Apotex Business Overview Table 91. Apotex Pirfenidone Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Apotex Pirfenidone Tablets Product Portfolio Table 93. Apotex Recent Development Table 94. Amneal Pharmaceuticals Company Information Table 95. Amneal Pharmaceuticals Business Overview Table 96. Amneal Pharmaceuticals Pirfenidone Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Amneal Pharmaceuticals Pirfenidone Tablets Product Portfolio Table 98. Amneal Pharmaceuticals Recent Development Table 99. Accord Healthcare Company Information Table 100. Accord Healthcare Business Overview Table 101. Accord Healthcare Pirfenidone Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Accord Healthcare Pirfenidone Tablets Product Portfolio Table 103. Accord Healthcare Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Pirfenidone Tablets Distributors List Table 107. Pirfenidone Tablets Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Pirfenidone Tablets Product Image Figure 2. Global Pirfenidone Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pirfenidone Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Pirfenidone Tablets Sales (2021-2032) & (K Units) Figure 5. Global Pirfenidone Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pirfenidone Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 200mg per Tablet Image Figure 9. 267mg per Tablet Image Figure 10. 801mg per Tablet Image Figure 11. Global Pirfenidone Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Pirfenidone Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Pirfenidone Tablets Sales Market Share by Type (2021-2032) Figure 14. Global Pirfenidone Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Pirfenidone Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Pirfenidone Tablets Revenue Market Share by Type (2021-2032) Figure 17. Retail Pharmacies Image Figure 18. Hospital and Clinic Image Figure 19. Other Image Figure 20. Global Pirfenidone Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pirfenidone Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pirfenidone Tablets Sales Market Share by Application (2021-2032) Figure 23. Global Pirfenidone Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Pirfenidone Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pirfenidone Tablets Revenue Market Share by Application (2021-2032) Figure 26. North America Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Pirfenidone Tablets Sales Market Share by Country (2021-2032) Figure 28. U.S. Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Pirfenidone Tablets Sales Market Share by Country (2021-2032) Figure 33. Germany Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Pirfenidone Tablets Sales Market Share by Country (2021-2032) Figure 40. China Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Pirfenidone Tablets Sales Market Share by Country (2021-2032) Figure 48. Brazil Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Pirfenidone Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Pirfenidone Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pirfenidone Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pirfenidone Tablets Revenue (2021-2032) & (US$ Million) Figure 59. North America Pirfenidone Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pirfenidone Tablets Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pirfenidone Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pirfenidone Tablets Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pirfenidone Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pirfenidone Tablets Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pirfenidone Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pirfenidone Tablets Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pirfenidone Tablets Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 200mg per Tablet
  • 267mg per Tablet
  • 801mg per Tablet
Applications
  • Retail Pharmacies
  • Hospital and Clinic
  • Other
Companies covered
  • Teva
  • Roche
  • Kawin
  • ScieGen Pharmaceuticals
  • Sandoz
  • Apotex
  • Amneal Pharmaceuticals
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pirfenidone Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pirfenidone Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pirfenidone Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pirfenidone Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pirfenidone Tablets Market Dynamics
  1. 2.1 Pirfenidone Tablets Industry Trends
  2. 2.2 Pirfenidone Tablets Industry Drivers
  3. 2.3 Pirfenidone Tablets Industry Opportunities and Challenges
  4. 2.4 Pirfenidone Tablets Industry Restraints
3 Pirfenidone Tablets Market by Manufacturers
  1. 3.1 Global Pirfenidone Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pirfenidone Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pirfenidone Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pirfenidone Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pirfenidone Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pirfenidone Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Pirfenidone Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pirfenidone Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pirfenidone Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pirfenidone Tablets Tier 1, Tier 2, and Tier 3
4 Pirfenidone Tablets Market by Type
  1. 4.1 Pirfenidone Tablets Type Introduction
  2. 4.1.1 200mg per Tablet
  3. 4.1.2 267mg per Tablet
  4. 4.1.3 801mg per Tablet
  5. 4.2 Global Pirfenidone Tablets Sales by Type
  6. 4.2.1 Global Pirfenidone Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pirfenidone Tablets Sales by Type (2021-2032)
  8. 4.2.3 Global Pirfenidone Tablets Sales Market Share by Type (2021-2032)
  9. 4.3 Global Pirfenidone Tablets Revenue by Type
  10. 4.3.1 Global Pirfenidone Tablets Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pirfenidone Tablets Revenue by Type (2021-2032)
  12. 4.3.3 Global Pirfenidone Tablets Revenue Market Share by Type (2021-2032)
5 Pirfenidone Tablets Market by Application
  1. 5.1 Pirfenidone Tablets Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Hospital and Clinic
  4. 5.1.3 Other
  5. 5.2 Global Pirfenidone Tablets Sales by Application
  6. 5.2.1 Global Pirfenidone Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pirfenidone Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Pirfenidone Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pirfenidone Tablets Revenue by Application
  10. 5.3.1 Global Pirfenidone Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pirfenidone Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Pirfenidone Tablets Revenue Market Share by Application (2021-2032)
6 Global Pirfenidone Tablets Sales by Region
  1. 6.1 Global Pirfenidone Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pirfenidone Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Pirfenidone Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Pirfenidone Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pirfenidone Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pirfenidone Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pirfenidone Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pirfenidone Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pirfenidone Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pirfenidone Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pirfenidone Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pirfenidone Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pirfenidone Tablets Revenue by Region
  1. 7.1 Global Pirfenidone Tablets Revenue by Region
  2. 7.1.1 Global Pirfenidone Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pirfenidone Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Pirfenidone Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Pirfenidone Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pirfenidone Tablets Revenue (2021-2032)
  8. 7.2.2 North America Pirfenidone Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pirfenidone Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Pirfenidone Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pirfenidone Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pirfenidone Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pirfenidone Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pirfenidone Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Pirfenidone Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pirfenidone Tablets Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Pirfenidone Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Pirfenidone Tablets Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Kawin
  14. 8.3.1 Kawin Company Information
  15. 8.3.2 Kawin Business Overview
  16. 8.3.3 Kawin Pirfenidone Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Kawin Pirfenidone Tablets Product Portfolio
  18. 8.3.5 Kawin Recent Developments
  19. 8.4 ScieGen Pharmaceuticals
  20. 8.4.1 ScieGen Pharmaceuticals Company Information
  21. 8.4.2 ScieGen Pharmaceuticals Business Overview
  22. 8.4.3 ScieGen Pharmaceuticals Pirfenidone Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ScieGen Pharmaceuticals Pirfenidone Tablets Product Portfolio
  24. 8.4.5 ScieGen Pharmaceuticals Recent Developments
  25. 8.5 Sandoz
  26. 8.5.1 Sandoz Company Information
  27. 8.5.2 Sandoz Business Overview
  28. 8.5.3 Sandoz Pirfenidone Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sandoz Pirfenidone Tablets Product Portfolio
  30. 8.5.5 Sandoz Recent Developments
  31. 8.6 Apotex
  32. 8.6.1 Apotex Company Information
  33. 8.6.2 Apotex Business Overview
  34. 8.6.3 Apotex Pirfenidone Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Apotex Pirfenidone Tablets Product Portfolio
  36. 8.6.5 Apotex Recent Developments
  37. 8.7 Amneal Pharmaceuticals
  38. 8.7.1 Amneal Pharmaceuticals Company Information
  39. 8.7.2 Amneal Pharmaceuticals Business Overview
  40. 8.7.3 Amneal Pharmaceuticals Pirfenidone Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Amneal Pharmaceuticals Pirfenidone Tablets Product Portfolio
  42. 8.7.5 Amneal Pharmaceuticals Recent Developments
  43. 8.8 Accord Healthcare
  44. 8.8.1 Accord Healthcare Company Information
  45. 8.8.2 Accord Healthcare Business Overview
  46. 8.8.3 Accord Healthcare Pirfenidone Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Accord Healthcare Pirfenidone Tablets Product Portfolio
  48. 8.8.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pirfenidone Tablets Value Chain Analysis
  2. 9.1.1 Pirfenidone Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pirfenidone Tablets Production Mode & Process
  6. 9.2 Pirfenidone Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pirfenidone Tablets Distributors
  9. 9.2.3 Pirfenidone Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst